 Home > Medical News > Latest Medical News > Henri Carrelizumab is about to be approved for new indications for nasopharyngeal carcinoma

Henri Carrelizumab is about to be approved for new indications for nasopharyngeal carcinoma

 Last Update: 2021-05-09
 Source: Internet
 Author: User

Tags

comprehensive review

pending

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 20, the NMPA official website showed that carrelizumab combined with cisplatin and gemcitabine was used for the indications for the application of the market for the indications of advanced nasopharyngeal carcinoma patients who have undergone second-line or above chemotherapy or have advanced or intolerable advanced nasopharyngeal carcinoma (Acceptance No.

At the 2020 ESMO conference, Hengrui announced the clinical results of the national multi-center, single-arm clinical trial CAPTAIN study.

The results of the study with a median follow-up of 9.

Currently in China, Hengrui's main competitor for nasopharyngeal cancer indications is Junshi.

Domestic PD-1 Nasopharyngeal Carcinoma Indication Application Status

In China, the incidence and mortality of nasopharyngeal cancer are significantly higher than the world average, and 50% of nasopharyngeal cancers worldwide occur in China.

Attachment: Timeline of Carrelizumab Review (http://db.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.